The pancreas is a soft, elongated organ tucked behind your stomach that performs two very different jobs at once: it produces digestive enzymes that break down the food you eat, and it releases hormones that keep your blood sugar within a safe range. Those two functions operate through entirely separate cell populations within the same organ, which is part of what makes the pancreas unusual. When either system falters, the consequences tend to be serious, from diabetes to malnutrition to one of the deadliest forms of cancer.
Where the Pancreas Sits and What It Looks Like
The pancreas is roughly the length of your hand and sits deep in the abdomen, behind the stomach and against the back wall of the abdominal cavity. Surgeons describe it as “retroperitoneal,” meaning it lies behind the membrane that lines the abdominal space rather than hanging freely within it.1Surgery (Oxford). Anatomy of the pancreas and spleen Its head nestles into the curve of the duodenum (the first stretch of your small intestine), while its narrower tail reaches leftward toward the spleen. A main duct runs through the center, collecting digestive secretions and funneling them into the duodenum.
Because of its deep position, the pancreas is difficult to examine by touch, which is one reason pancreatic diseases are often caught late. You can’t feel a swollen pancreas the way you might feel a swollen lymph node. Imaging or blood tests are usually needed to spot trouble.
Two Organs in One
What makes the pancreas distinctive is that it functions as both a digestive gland and a hormone-producing organ. About 98% of the pancreatic mass is devoted to its digestive (exocrine) role, made up of clusters of enzyme-secreting cells called acinar cells and the duct cells that carry their output. The remaining roughly 2% consists of tiny clusters called islets of Langerhans, which handle the hormone (endocrine) side.2Pancreapedia: Exocrine Pancreas Knowledge Base. Structure of Islets and Vascular Relationship to the Exocrine Pancreas Those islets are scattered throughout the organ like tiny islands in a sea of digestive tissue, and they contain at least five different hormone-producing cell types.
These two systems share the same blood supply and physical space, but their outputs go in different directions. Digestive enzymes travel through ducts into the intestine. Hormones enter the bloodstream directly. The two sides do influence each other, though, in ways researchers are still mapping. Insulin from the islets, for example, helps regulate how nearby acinar cells function, and the paracrine signaling within islets involves a web of interactions among hormones, immune cells, blood vessel cells, and nerve fibers.3PubMed Central. Paracrine signaling in islet function and survival
How the Pancreas Helps You Digest Food
Every time you eat, acinar cells in the pancreas produce a cocktail of digestive enzymes, including lipase for breaking down fats, proteases for proteins, and amylase for starches. These enzymes are manufactured in inactive forms (so they don’t digest the pancreas itself) and are activated only after they reach the small intestine. The pancreas also secretes a bicarbonate-rich fluid, roughly two to three liters per day, through its duct system.4PubMed Central. Physiology and pathophysiology of bicarbonate secretion by pancreatic duct epithelium That bicarbonate neutralizes the acid pouring out of your stomach, creating the right pH for the enzymes to work and protecting the intestinal lining from acid damage.5PubMed Central. Pancreatic ductal bicarbonate secretion: challenge of the acinar Acid load
This system doesn’t run on autopilot. Pancreatic secretion is tightly controlled by gut hormones, especially secretin and cholecystokinin (CCK). When acidic stomach contents enter the duodenum, intestinal cells release secretin, which tells the pancreas to ramp up bicarbonate output. When partially digested proteins and fats arrive, intestinal cells release CCK, which stimulates the acinar cells to pour out enzymes.6The American Journal of Clinical Nutrition. The neurohumoral control of pancreatic exocrine secretion In humans, CCK appears to act mainly through nerve pathways rather than directly on acinar cells, giving the brain an indirect role in fine-tuning digestive output.7PubMed. How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans Other signaling molecules, including neurotensin, motilin, and pancreatic polypeptide from the islets themselves, further adjust the response.8Pancreatology. Neural Hormonal Regulation of Exocrine Pancreatic Secretion
How the Pancreas Regulates Blood Sugar
The endocrine side of the pancreas revolves around two hormones with opposing effects: insulin and glucagon. Beta cells within the islets of Langerhans produce insulin, which lowers blood sugar by signaling your muscles, fat, and liver to absorb glucose from the bloodstream. Alpha cells produce glucagon, which raises blood sugar by prompting the liver to release stored glucose. Delta cells produce somatostatin, which acts locally to modulate both insulin and glucagon secretion.9PubMed Central. Intercellular Communication in the Islet of Langerhans in Health and Disease
Beta cells act as glucose sensors. When blood sugar rises after a meal, glucose enters the beta cell and triggers a chain of metabolic events that changes the cell’s electrical activity, increases calcium inside the cell, and causes insulin-containing packets to fuse with the cell membrane and release insulin into the blood.10PubMed Central. Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men Other nutrients, including amino acids and fatty acids, can boost this process, but glucose is the primary trigger.11PubMed Central. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes
When blood sugar drops between meals or during exercise, alpha cells release glucagon, which signals the liver to break down glycogen into glucose and release it into the bloodstream. The liver’s glucose production is a major factor in keeping blood sugar stable around the clock.12PubMed Central. Molecular pathophysiology of hepatic glucose production The balance between insulin and glucagon keeps blood glucose within a narrow range, and the constant back-and-forth communication among islet cell types is what makes the system responsive without overshooting.
The Incretin Effect and Why Eating Matters More Than an IV
An interesting quirk of this system: eating sugar by mouth produces a larger insulin response than receiving the same amount of glucose directly into a vein. This amplification is called the incretin effect, and it’s driven by gut hormones known as GIP and GLP-1 that are released when food reaches the intestine.13PubMed. The incretin system in healthy humans: The role of GIP and GLP-1 These hormones travel through the blood to the beta cells and enhance insulin release on top of what glucose alone would produce. The incretin effect accounts for a substantial share of the total insulin response to a meal, and it’s one of the reasons that managing blood sugar involves more than just counting glucose grams. The type of carbohydrate, how quickly your stomach empties, and how efficiently you absorb nutrients all feed into the equation.
GLP-1-based drugs have become blockbuster medications in recent years, used for both type 2 diabetes and weight loss. They work by mimicking or prolonging the activity of this natural incretin signal, essentially borrowing the pancreas’s own amplification trick and extending it.
The Nervous System Connection
The pancreas isn’t just controlled by hormones from the gut. It’s also densely wired into the autonomic nervous system, the part of your nervous system that runs unconscious functions like heart rate and digestion. The vagus nerve (the “rest and digest” nerve) directly stimulates both enzyme secretion from acinar cells and insulin release from beta cells. The sympathetic nervous system, which handles “fight or flight” responses, does the opposite: it reduces blood flow to the pancreas and suppresses both digestive secretion and insulin output.14PubMed. Autonomic pathways regulating pancreatic exocrine secretion
This dual wiring explains why stress can disrupt digestion and blood sugar regulation simultaneously. Under chronic stress, sympathetic tone stays elevated, and the pancreas gets persistent signals to dial down both of its major functions. Research in rats has shown that parasympathetic stimulation increases beta-cell proliferation (the growth of new insulin-producing cells), while sympathetic activation suppresses it.15PubMed Central. The autonomic nervous system regulates pancreatic β-cell proliferation in adult male rats Whether this translates directly to humans is still under study, but it underscores how deeply the brain and the pancreas are linked.
When the Endocrine Side Fails
The most familiar diseases of the pancreas involve its blood-sugar-regulating function. In type 1 diabetes, the immune system’s T cells destroy the beta cells over a period of years, eventually leaving the pancreas unable to produce meaningful amounts of insulin.16PubMed Central. T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes The process is autoimmune, meaning the body’s own defenses attack its own tissue, and by the time symptoms appear, a large fraction of beta cells are already gone.17PubMed Central. Apoptosis of pancreatic β-cells in Type 1 diabetes
Type 2 diabetes involves a different problem. The body’s tissues become resistant to insulin’s signal, and over time the beta cells struggle to compensate. Both insufficient insulin release and the failure of the body’s cells to respond to it contribute to the disease.18PubMed Central. Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress The beta cells don’t disappear the way they do in type 1, but they become dysfunctional. Research has found that this dysfunction in the remaining beta cells is actually a key early feature of type 2 diabetes, not just a late consequence.19PubMed. Dysfunction of Persisting β Cells Is a Key Feature of Early Type 2 Diabetes Pathogenesis In both types, the downstream effect is the same: glucose builds up in the bloodstream because the pancreas can’t properly manage it.
When the Digestive Side Fails
Pancreatitis, or inflammation of the pancreas, is perhaps the most dramatic failure of the digestive side. It occurs when the protective mechanism that keeps digestive enzymes inactive inside the pancreas breaks down. Premature activation of trypsinogen, the precursor to the powerful protein-digesting enzyme trypsin, can trigger the pancreas to start digesting itself.20PubMed Central. Pathologically relevant trypsinogen activation in pancreatitis Acute pancreatitis can range from a brief, painful episode to a life-threatening emergency. Chronic pancreatitis leads to progressive scarring and long-term loss of pancreatic function.
A less dramatic but still debilitating consequence is exocrine pancreatic insufficiency, or EPI. In this condition, the pancreas doesn’t deliver enough digestive enzymes to the intestine to properly break down food, particularly fat. The most common symptoms are oily, foul-smelling stools (a sign that fat is passing through undigested), weight loss, bloating, and abdominal discomfort.21PubMed. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities EPI can stem from chronic pancreatitis, pancreatic surgery, cystic fibrosis, or any condition that damages or blocks the pancreatic duct. Because it causes poor absorption of nutrients (not just fat, but also fat-soluble vitamins like A, D, E, and K), untreated EPI can lead to nutritional deficiencies beyond simple weight loss.22PubMed. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review
Pancreatic Cancer and Why It Is So Difficult to Treat
Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer, is one of the deadliest cancers in the world. One reason is late detection: the pancreas’s deep, hidden position means tumors often grow without obvious symptoms until they’ve spread. Another reason is the tumor’s own biology. Pancreatic cancer tumors are surrounded by an unusually dense layer of non-cancerous tissue called the stroma, which can make up the majority of the tumor mass. This stromal barrier supports tumor growth, promotes spread to other organs, and physically blocks chemotherapy drugs from reaching the cancer cells.23PubMed Central. The pancreas cancer microenvironment The cellular and spatial complexity of this microenvironment is an active area of research, with scientists trying to find ways to disrupt it and make tumors more vulnerable to treatment.24PubMed Central. Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Early detection efforts are focusing on new blood-based biomarkers and imaging techniques. Researchers have identified changes in circulating proteins, tiny RNA fragments, and tumor DNA in the blood of people with pancreatic cancer and even its precancerous stages.25PubMed Central. Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer There is growing interest in using artificial intelligence to sift through routine medical records and imaging for subtle early warning signs that a clinician might miss, with the goal of catching the disease at a stage where surgery is still an option.26Evolutionary Intelligence. Artificial intelligence for early detection of pancreatic cancer: pre-diagnostic detection across imaging, biomarkers, and EHRs: a systematic review
Treating a Failing Pancreas
When the exocrine side stops working well enough, the standard treatment is pancreatic enzyme replacement therapy (PERT). You take capsules containing lipase, protease, and amylase with every meal and snack, essentially providing from outside what the pancreas can no longer supply from within. Starting doses are typically in the range of 40,000 to 50,000 units of lipase per meal, with adjustments upward if needed.27PubMed. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types A systematic review and meta-analysis found that PERT significantly improved fat absorption, reduced symptoms, and improved quality of life in people with chronic pancreatitis, with higher doses and enteric-coated formulations tending to work better.28Gut. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis These capsules need to be taken during the meal, not before or after, so the enzymes mix with food at the right time.
For the endocrine side, the technology landscape has changed dramatically. Artificial pancreas systems pair an insulin pump with a continuous glucose monitor and an algorithm that automatically adjusts insulin delivery, preventing the dangerous blood sugar swings that people with type 1 diabetes face daily.29PubMed Central. Artificial pancreas: the past and the future These closed-loop systems have moved from experimental devices to commercially available products over the past decade, and they represent one of the biggest quality-of-life improvements for people managing insulin-dependent diabetes.
Stem Cell-Derived Islets and the Frontier of Replacement
The most ambitious goal in pancreas research is replacing destroyed beta cells entirely. Islet transplantation from donor organs has been possible for years but is limited by a severe shortage of donors and the need for lifelong immunosuppression. Stem cell-derived beta cells offer a potential way around both problems, since they could theoretically provide an unlimited supply of insulin-producing cells.30PubMed Central. Overcoming the Limitations of Stem Cell-Derived Beta Cells
A 2025 trial published in the New England Journal of Medicine reported striking results: after infusion of stem cell-derived islet cells called zimislecel, all 12 participants with type 1 diabetes showed evidence of the transplanted cells functioning, and 10 of the 12 were completely off insulin injections at one year.31PubMed. Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes The trial is small, the follow-up is short, and participants still required immunosuppressive drugs. But the fact that lab-grown cells could take over from a destroyed pancreas in the majority of recipients is a genuine milestone. Encapsulation strategies that shield transplanted cells from immune attack without drugs are under development, though none have yet proven durable in humans.
A Vertebrate Innovation
If you’re wondering whether all animals have a pancreas, the answer is no. Invertebrates lack a distinct pancreas, though some have cells in the gut or brain that perform comparable hormone-producing functions.32PubMed. Developmental biology of the pancreas The pancreas as a discrete organ is a vertebrate feature. In humans, it begins forming during the fourth week of embryonic development, budding from the same stretch of embryonic gut tube that gives rise to the liver and duodenum.33PubMed Central. Development of the human pancreas from foregut to endocrine commitment Two separate buds (dorsal and ventral) eventually fuse into the single organ you carry as an adult. That developmental origin is why the pancreas sits where it does, nestled against the duodenum with its main duct emptying right into the intestine. It was built to be close to its primary customer.